Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human interleukin-12

EU orphan designation number: EU/3/16/1727   
Active ingredient: Recombinant human interleukin-12
Indication: Treatment of acute radiation syndrome
Sponsor: Coté Orphan Consulting UK Limited
27 Old Gloucester Street, London WC1N 3AX, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/116/16 (2016)5634 of 29/08/2016